Skip to main content
OpenTrials

Clinical trial condition

Systemic Vasculitis

Explore clinical trials studying Systemic Vasculitis. Study availability and eligibility vary by location and protocol.

183 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Systemic Vasculitis trial results

Completed

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis

NCT00987389

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 98 locations
View Trial Details
Completed

A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01750697

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations
  • University of Louisville Research Foundation, Inc; Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • COLUMBIA PRESBYTERIAN MEDICAL CENTER, Research Pharmacy, William Black Medical Research Building New York, United States
  • Cincinnati Childrens Hospital Cincinnati, Ohio, United States
View all 23 locations
View Trial Details
Completed

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

NCT02020889

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Bethesda, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

The ANCA Vasculitis Questionnaire (AAV-PRO©)

NCT02507024

Conditions
ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +28 more
Locations
  • University of South Florida Tampa, Florida, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

NCT00104299

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +18 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Boston University Boston, Massachusetts, United States
  • Mayo Clinic Foundation Rochester, Minnesota, United States
View Trial Details

Related conditions